The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Cupertino.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Acorn Campus Ventures, startups are often financed by DEFTA Partners, iD SoftCapital Group, Technology Associates Management. The meaningful sponsors for the fund in investment in the same round are iD SoftCapital Group, Harbinger Ventures, Technology Associates Management. In the next rounds fund is usually obtained by iD SoftCapital Group, Majuven, Harbinger Ventures.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Semiconductor. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Eureka Therapeutics, Leopard Logic, Waterstone Pharmaceuticals.
The current fund was established by David Tsang. The overall number of key employees were 10.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2004. This Acorn Campus Ventures works on 15 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2012. Speaking about the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Flat Medical | 30 Nov 2017 | Oakland, California, United States | |||
Eureka Therapeutics | $21M | 23 Sep 2014 | California, United States | ||
Waterstone Pharmaceuticals | $3M | 21 Aug 2012 | Jiang'an District, Hubei, China | ||
Eureka Therapeutics | $1M | 13 Nov 2008 | California, United States | ||
Innolight | 01 Apr 2008 | Jiangsu | |||
$1M | 22 Oct 2007 | San Jose, California, United States | |||
$1M | 07 Aug 2007 | San Jose, California, United States | |||
Optovue | $10M | 30 Mar 2007 | Fremont, California, United States | ||
$25M | 14 Jun 2006 | Cupertino, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Flat Medical | 30 Nov 2017 | Oakland, California, United States | |||
Eureka Therapeutics | $21M | 23 Sep 2014 | California, United States | ||
Waterstone Pharmaceuticals | $3M | 21 Aug 2012 | Jiang'an District, Hubei, China | ||
Eureka Therapeutics | $1M | 13 Nov 2008 | California, United States | ||
Innolight | 01 Apr 2008 | Jiangsu | |||
$1M | 22 Oct 2007 | San Jose, California, United States | |||
$1M | 07 Aug 2007 | San Jose, California, United States | |||
Optovue | $10M | 30 Mar 2007 | Fremont, California, United States | ||
$25M | 14 Jun 2006 | Cupertino, California, United States |